What Should Hypertension Sponsors Measure Before Launch?

A Market Feasibility Test (MFT) is a short, pre-launch recruitment test that helps sponsors assess whether the right patients can be reached, engaged, and qualified before full enrollment begins.

And in hypertension trials, broad audience reach does not answer the real question.

The bigger issue is whether that response holds up when measurable criteria, comorbidities, medication requirements, and next-step intent start to narrow the field.

• Can high patient interest translate into qualified progression?

• Where does qualification begin to tighten?

• And what should sponsors know before those challenges start consuming site time?

This whitepaper breaks down what our latest data revealed: 215 screener completions in 2 days, a 53% qualified lead rate, strong next-step intent, and a clearer case for earlier qualification before handoff.  

See the Full Findings